Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

S.African health insurer Discovery in touch with vaccine makers

03/29/2021 | 02:48pm EST
The logo of South Africa's Discovery group in seen on its headquarters in Sandton

JOHANNESBURG (Reuters) - South African health insurer Discovery Ltd said on Monday it was in contact with all COVID-19 vaccine producers but cannot independently source vaccines as procurement and distribution is in the hands of the government.

As in many countries, vaccine procurement in South Africa is centralised and controlled by government but the pace of procurement and inoculation has been slow, with less than 250,000 people, or just 0.5% of the population vaccinated so far.

This has prompted calls from health experts to allow the private sector to source vaccines to bolster government efforts.

"While we (Discovery) might be in contact with vaccine manufacturers, the acquisition of the vaccine and the policy for who receives it and in what sequence remains the exclusive responsibility of government, until such time as government informs otherwise," said Ryan Noach, CEO of the company's medical scheme Discovery Health.

"We have been in regular liaison with vaccine manufacturers since September 2020," Noach said in an emailed response to Reuters. He said the company is taking all measures to "ensure the procurement is efficient, and stock available quickly, especially for the most at risk." 

South Africa's vaccine rollout faced a blow in early February when it decided to halt the rollout of AstraZeneca's shots on concerns about its effectiveness against the 501Y.V2 variant that caused a huge spurt in infections late last year.

The country has since opted for Johnson & Johnson's vaccine under an "implementation study."

In a note to policyholders on Friday, Discovery's group CEO Adrian Gore said the company was aiming to vaccinate its three million adult policyholders, with the capacity of 50,000 vaccinations per day starting in May, if vaccine supplies are on time.

"This will enable all of Discovery's 550,000 high-risk members to be vaccinated within a few weeks," he said.

South Africa's Health Ministry did not immediately respond to Reuters request for comment when asked about private vaccine procurement.

(Reporting by Promit Mukherjee. Editing by Jane Merriman)

By Promit Mukherjee

ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
DISCOVERY LIMITED 0.39% 138.14 End-of-day quote.-10.03%
DOW JONES AFRICA TITANS 50 INDEX 1.14% 518.56 Delayed Quote.-1.99%
DOW JONES SOUTH AFRICA(ZAR) -0.14% 1947.68 Delayed Quote.10.59%
S&P AFRICA 40 INDEX 0.44% 167.27 Delayed Quote.-3.73%
Latest news "Economy & Forex"
02:10pRetail investors added to Didi selloff after delisting news
02:04pBrazil's soybean planting hits 94%, but southern states face drought risk
02:01pOil rebounds towards $72 on Omicron hopes and Iran talks
01:53pBLOCK TRADE - BAVARIAN NORDIC PRIMARY AEO : Bookrunner says books close at 7.15pm uk / 8.15pm cet
01:52pBLOCK TRADE - BAVARIAN NORDIC : Bookrunner says deal expected to price at dkk 268; books are covered at that price (indicated demand exceeds deal size)
01:45pOil prices extend gains, wti rises more than $3 to session high of $69.28/bbl
01:45pSackler family says billions collected from Purdue not abuse of bankruptcy law
01:44pECB to redesign euro banknotes in inclusion effort
01:41pHERBERT DIESS : Volkswagen's Diess to remain CEO, but with fewer powers - sources
01:40pEuro zone upbeat on growth despite Omicron, to continue fiscal support
Latest news "Economy & Forex"